• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Chim Acta. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China

tetano

Editor, Senior Moderator
Clin Chim Acta. 2020 Apr 24. pii: S0009-8981(20)30179-0. doi: 10.1016/j.cca.2020.04.024. [Epub ahead of print]
Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China.


Sun S[SUP]1[/SUP], Cai X[SUP]2[/SUP], Wang H[SUP]3[/SUP], He G[SUP]4[/SUP], Lin Y[SUP]5[/SUP], Lu B[SUP]6[/SUP], Chen C[SUP]7[/SUP], Pan Y[SUP]8[/SUP], Hu X[SUP]9[/SUP].

Author information




Abstract

BACKGROUND:

In December 2019, coronavirus disease 2019 (COVID-19) was first found in Wuhan, China and soon was reported all around the world.
METHODS:

All confirmed cases with COVID-19 in Wenzhou from January 19 to February 20, 2020, were collected and analyzed. Of the 116 patients with COVID-19, 27 were diagnosed as severe cases. Among severe cases, 9 were treated in ICU. The data of blood routine examination were analyzed and compared among common patients (as common group), severe patients admitted to intensive care unit (as severe ICU group) and severe patients not admitted to ICU (as severe non-ICU group). The blood routine examination results were dynamically observed in the above groups after admission.
RESULTS:

Patients with COVID-19 have lower counts of leucocytes, lymphocytes, eosinophils, platelets, and hemoglobin, but have higher neutrophil-lymphocyte ratio (NLR) and monocyte-lymphocyte ratio (MLR), which were compared with controls (P<0.001). In severe ICU group, patients have the lowest count of lymphocytes, but the highest neutrophil count and NLR among the above three groups (all P values <0.05); NLR and MLR indicators were combined for diagnostic efficacy analysis of severe COVID-19, and its area under the curve reached 0.925. The odds ratio of the delay in days to the start of the increase of eosinophil count for predicting the outcome of patients with severe COVID-19 was 2.291 after age adjusted.
CONCLUSIONS:

Patients with COVID-19 have abnormal peripheral blood routine examination results. Dynamic surveillance of peripheral blood system especially eosinophils is helpful in the prediction of severe COVID-19 cases.
Copyright ? 2020. Published by Elsevier B.V.



KEYWORDS:

COVID-19; Lymphocyte; Neutrophil-Lymphocyte ratio; Peripheral blood; eosinophils


PMID:32339487DOI:10.1016/j.cca.2020.04.024
 
Back
Top